Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity (PEARL)
|ClinicalTrials.gov Identifier: NCT01567774|
Recruitment Status : Unknown
Verified May 2013 by Francesco Pelliccia, University of Roma La Sapienza.
Recruitment status was: Recruiting
First Posted : March 30, 2012
Last Update Posted : May 6, 2013
University of Roma La Sapienza
Information provided by (Responsible Party):
Francesco Pelliccia, University of Roma La Sapienza
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2014|
|Estimated Study Completion Date :||June 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Pelliccia F, Rosano G, Marazzi G, Vitale C, Spoletini I, Franzoni F, Speziale G, Polacco M, Greco C, Gaudio C. Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study. Eur J Pharmacol. 2014 Feb 15;725:18-22. doi: 10.1016/j.ejphar.2014.01.006. Epub 2014 Jan 17.